Use of Intrapyloric Botulinum Injections in Children
NCT04250844 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-12-08
Summary
This study aims to evaluate the effect of intrapyloric botulinum toxin in children with feeding disorders.
Conditions
- Vomiting
- Feeding Disorders
- Gastroparesis
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Rachel Rosen, MD, MPH · Boston Children's Hospital
Eligibility
- Min Age
- 30 Days
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-10
- Primary Completion
- 2021-05-31
- Completion
- 2021-05-31
Countries
- United States
Study Locations
More Related Trials
-
BOTOX® Treatment in Pediatric Lower Limb Spasticity
NCT01603628 ·Status: COMPLETED ·Phase: PHASE3
-
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
NCT01603615 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects
NCT00976443 ·Status: COMPLETED ·Phase: PHASE1
-
Botulinum Toxin Injection in Hypercontractile Esophagus
NCT01955174 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Human Botulism Immunoglobulin in Infants With Botulism
NCT00004401 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin (BOTOX) for Cerebral Palsy
NCT00060957 ·Status: COMPLETED ·Phase: PHASE2
-
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
NCT01852045 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Repeated Botulinum Toxin Injections in Children With Cerebral Palsy
NCT05295563 ·Status: COMPLETED
-
Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy
NCT04443244 ·Status: COMPLETED ·Phase: PHASE2
-
Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence
NCT02414425 ·Status: COMPLETED ·Phase: PHASE3
-
Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia
NCT03363113 ·Status: COMPLETED
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00439140 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Botox in Obstructed Defecation Syndrome
NCT02160288 ·Status: TERMINATED ·Phase: PHASE2
-
Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation
NCT02361749 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin
NCT00746304 ·Status: COMPLETED
-
Efficacy of Botulinum Toxin Type A for Acute Acquired Comitant Esotropia: An Age-Stratified Two-Year Follow-Up Study
NCT06966999 ·Status: COMPLETED ·Phase: NA
-
Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00915525 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Botox on Children With Cerebral Palsy
NCT00503620 ·Status: COMPLETED
-
Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females
NCT01042119 ·Status: COMPLETED
-
Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele
NCT00175123 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults
NCT03603665 ·Status: COMPLETED ·Phase: PHASE1
-
Botulinum Toxin and Saliva Management in Tracheotomised Patients
NCT00973999 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome
NCT01167257 ·Status: COMPLETED ·Phase: PHASE2
-
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)
NCT02097121 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00910845 ·Status: COMPLETED ·Phase: PHASE3